Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...
Here is the latest financial fact sheet of SHUKRA PHARMA. For more details, see the SHUKRA PHARMA quarterly results and SHUKRA PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 2.0 |
No. of shares | m | 43.79 |
1 Week | % | 12.4 |
1 Month | % | 9.9 |
1 Year | % | 348.8 |
52 week H/L | Rs | 97.0/20.4 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
SHUKRA PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 166 | 61 | 57 | 108 | 89 | |
Low | Rs | 26 | 26 | 25 | 43 | 11 | |
Sales per share (Unadj.) | Rs | 30.0 | 63.4 | 71.3 | 130.5 | 53.7 | |
Earnings per share (Unadj.) | Rs | 2.9 | 0.2 | 1.2 | 4.8 | 4.0 | |
Diluted earnings per share | Rs | 0.1 | 0.0 | 0.0 | 0.2 | 1.0 | |
Cash flow per share (Unadj.) | Rs | 9.1 | 9.6 | 10.6 | 15.4 | 5.7 | |
Dividends per share (Unadj.) | Rs | 0.50 | 0 | 0 | 0.50 | 0.50 | |
Adj. dividends per share | Rs | 0.02 | 0.00 | 0.00 | 0.02 | 0.13 | |
Avg Dividend yield | % | 0.5 | 0 | 0 | 0.7 | 1.0 | |
Book value per share (Unadj.) | Rs | 97.9 | 98.2 | 99.4 | 104.1 | 23.1 | |
Adj. book value per share | Rs | 3.5 | 3.5 | 3.6 | 3.7 | 5.8 | |
Shares outstanding (eoy) | m | 1.57 | 1.57 | 1.57 | 1.57 | 10.96 | |
Price / Sales ratio | x | 3.2 | 0.7 | 0.6 | 0.6 | 0.9 | |
Avg P/E ratio | x | 32.6 | 191.4 | 34.0 | 15.8 | 12.4 | |
P/CF ratio (eoy) | x | 10.6 | 4.5 | 3.8 | 4.9 | 8.8 | |
Price / Book Value ratio | x | 1.0 | 0.4 | 0.4 | 0.7 | 2.2 | |
Dividend payout | % | 16.9 | 0 | 0 | 10.4 | 12.4 | |
Avg Mkt Cap | Rs m | 151 | 68 | 64 | 118 | 547 | |
Total wages/salary | Rs m | 19 | 43 | 37 | 46 | 44 |
SHUKRA PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 47 | 100 | 112 | 205 | 588 | |
Other income | Rs m | 0 | 0 | 4 | 1 | 12 | |
Total revenues | Rs m | 47 | 100 | 116 | 206 | 600 | |
Gross profit | Rs m | 16 | 16 | 12 | 29 | 54 | |
Depreciation | Rs m | 10 | 15 | 15 | 17 | 18 | |
Interest | Rs m | 0 | 0 | 0 | 3 | 3 | |
Profit before tax | Rs m | 7 | 2 | 1 | 10 | 44 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 3 | 1 | -1 | 3 | 0 | |
Profit after tax | Rs m | 5 | 0 | 2 | 8 | 44 | |
Gross profit margin | % | 35.0 | 16.5 | 11.2 | 14.1 | 9.1 | |
Effective tax rate | % | 36.2 | 79.1 | -92.1 | 26.3 | 0.8 | |
Net profit margin | % | 9.8 | 0.4 | 1.7 | 3.7 | 7.5 |
SHUKRA PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 111 | 145 | 161 | 159 | 531 | |
Current liabilities | Rs m | 40 | 70 | 70 | 124 | 425 | |
Net working cap to sales | % | 150.2 | 75.0 | 80.6 | 17.1 | 18.0 | |
Current ratio | x | 2.8 | 2.1 | 2.3 | 1.3 | 1.2 | |
Inventory Days | Days | 4 | 2 | 6 | 0 | 0 | |
Debtors Days | Days | 414,309,733 | 291,441,225 | 3,178 | 1,319 | 1,873 | |
Net fixed assets | Rs m | 173 | 191 | 195 | 192 | 219 | |
Share capital | Rs m | 16 | 16 | 16 | 16 | 39 | |
"Free" reserves | Rs m | 138 | 138 | 140 | 148 | 214 | |
Net worth | Rs m | 154 | 154 | 156 | 164 | 253 | |
Long term debt | Rs m | 61 | 81 | 98 | 31 | 38 | |
Total assets | Rs m | 284 | 335 | 356 | 351 | 750 | |
Interest coverage | x | 725.0 | 86.5 | 4.0 | 4.5 | 16.8 | |
Debt to equity ratio | x | 0.4 | 0.5 | 0.6 | 0.2 | 0.1 | |
Sales to assets ratio | x | 0.2 | 0.3 | 0.3 | 0.6 | 0.8 | |
Return on assets | % | 1.6 | 0.1 | 0.6 | 3.0 | 6.3 | |
Return on equity | % | 3.0 | 0.2 | 1.2 | 4.6 | 17.4 | |
Return on capital | % | 3.4 | 0.7 | 0.5 | 6.7 | 16.2 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 3 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | -3 | 0 | 0 | 0 |
SHUKRA PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 3 | 12 | 5 | 80 | 32 | |
From Investments | Rs m | -25 | -31 | -19 | -15 | -44 | |
From Financial Activity | Rs m | 24 | 18 | 17 | -67 | 49 | |
Net Cashflow | Rs m | 2 | -1 | 4 | -2 | 37 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Dakshesh Shah | COMP SEC: Arpita Kabraa | YEAR OF INC: 1993 | BSE CODE: 524632 | FV (Rs): 10 | DIV YIELD (%): 0.1 |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare SHUKRA PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.